Stephane Biguet
Known title: EVP & CFOCIK: 0001592739
Associated companies
Transaction History
| SLB | ▲ Buy | Grant | 3,504 | $0 | 3/13/2026 | View on chart |
| SLB | ▼ Sell | Tax Withholding | 1,379 | $61K | 3/13/2026 | View on chart |
| SLB | ▼ Sell | Open Market | 61,017 | $3.0M | 1/26/2026 | View on chart |
| SLB | ▲ Buy | Grant | 51,885 | $0 | 1/23/2026 | View on chart |
| SLB | ▼ Sell | Tax Withholding | 20,418 | $1.0M | 1/23/2026 | View on chart |
| SLB | ▼ Sell | Tax Withholding | 6,372 | $297K | 1/18/2026 | View on chart |
| SLB | ▲ Buy | Option Exercise | 15,780 | $0 | 1/18/2026 | View on chart |
| SLB | ▼ Sell | Open Market | 38,447 | $1.4M | 11/13/2025 | View on chart |
| SLB | ▲ Buy | Grant | 12,451 | $0 | 3/7/2025 | View on chart |
| SLB | ▼ Sell | Tax Withholding | 4,900 | $200K | 3/7/2025 | View on chart |
| SLB | ▼ Sell | Open Market | 45,000 | $2.0M | 1/21/2025 | View on chart |
| SLB | ▲ Buy | Grant | 74,836 | $0 | 1/17/2025 | View on chart |
| SLB | ▼ Sell | Tax Withholding | 29,613 | $1.3M | 1/17/2025 | View on chart |
| SLB | ▲ Buy | Option Exercise | 24,414 | $0 | 1/17/2025 | View on chart |
| SLB | ▼ Sell | Tax Withholding | 9,607 | $414K | 1/17/2025 | View on chart |
| SLB | ▼ Sell | Open Market | 11,520 | $512K | 11/13/2024 | View on chart |
| SLB | ▼ Sell | Open Market | 50,048 | $2.5M | 7/22/2024 | View on chart |
| SLB | ▼ Sell | Tax Withholding | 6,613 | $326K | 3/1/2024 | View on chart |
| SLB | ▲ Buy | Grant | 16,805 | $0 | 3/1/2024 | View on chart |
| SLB | ▼ Sell | Open Market | 6,250 | $304K | 2/26/2024 | View on chart |
| SLB | ▼ Sell | Open Market | 6,250 | $330K | 1/29/2024 | View on chart |
| SLB | ▲ Buy | Option Exercise | 33,610 | $0 | 1/20/2024 | View on chart |
| SLB | ▼ Sell | Tax Withholding | 13,226 | $657K | 1/20/2024 | View on chart |
| SLB | ▲ Buy | Grant | 17,340 | $0 | 1/19/2024 | View on chart |
| SLB | ▼ Sell | Tax Withholding | 46,637 | $2.3M | 1/19/2024 | View on chart |
| SLB | ▲ Buy | Grant | 100,830 | $0 | 1/19/2024 | View on chart |
| SLB | ▼ Sell | Open Market | 6,250 | $337K | 12/26/2023 | View on chart |
| SLB | ▼ Sell | Open Market | 6,250 | $328K | 11/27/2023 | View on chart |
| SLB | ▼ Sell | Open Market | 6,250 | $352K | 10/30/2023 | View on chart |
| SLB | ▼ Sell | Open Market | 6,250 | $368K | 9/25/2023 | View on chart |
| SLB | ▼ Sell | Open Market | 6,250 | $355K | 8/28/2023 | View on chart |
| SLB | ▼ Sell | Open Market | 6,250 | $359K | 7/31/2023 | View on chart |
| SLB | ▼ Sell | Open Market | 6,250 | $292K | 6/26/2023 | View on chart |
| SLB | ▼ Sell | Open Market | 6,250 | $273K | 5/30/2023 | View on chart |
| SLB | ▼ Sell | Open Market | 6,250 | $310K | 4/24/2023 | View on chart |
| SLB | ▼ Sell | Open Market | 6,250 | $280K | 3/20/2023 | View on chart |
| SLB | ▲ Buy | Grant | 18,995 | $0 | 3/3/2023 | View on chart |
| SLB | ▼ Sell | Tax Withholding | 7,475 | $412K | 3/3/2023 | View on chart |
| SLB | ▲ Buy | Grant | 94,975 | $0 | 1/20/2023 | View on chart |
| SLB | ▲ Buy | Grant | 75,980 | $0 | 1/20/2023 | View on chart |
| SLB | ▼ Sell | Tax Withholding | 67,379 | $3.9M | 1/20/2023 | View on chart |
| SLB | ▲ Buy | Grant | 3,822 | $0 | 3/4/2022 | View on chart |
| SLB | ▼ Sell | Tax Withholding | 1,504 | $58K | 3/4/2022 | View on chart |
| SLB | ▲ Buy | Grant | 34,398 | $0 | 1/21/2022 | View on chart |
| SLB | ▲ Buy | Grant | 52,500 | $0 | 1/21/2022 | View on chart |
| SLB | ▼ Sell | Tax Withholding | 34,345 | $1.3M | 1/21/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
SLB Q3 Earnings Preview: Barclays Lowers Price Target to $66
SLB is preparing for its Q3 earnings release, with analysts expecting a decline in results. Barclays recently maintained an Overweight rating but lowered its price target to $66. This move comes as the stock trades near its 52-week low, reflecting broader market caution and sector-specific pressures.
SLB Q3 Earnings Preview: Barclays Lowers Price Target to $66. SLB is preparing for its Q3 earnings release, with analysts expecting a decline in results. Barclays recently maintained an Overweight rating but lowered its price target to $66. This move comes as the stock trades near its 52-week low, reflecting broader market caution and sector-specific pressures.